Antibodies directed to CD20 and uses thereof

Details for Australian Patent Application No. 2006252733 (hide)

Owner AstraZeneca AB

Inventors Yang, Xiaodong; Blakey, David Charles; Tabrizi, Mohammad; Green, Larry L.; Queva, Christophe; GazitBornstein, Gadi

Agent Allens Arthur Robinson

Pub. Number AU-A-2006252733

PCT Pub. Number WO2006/130458

Priority 60/686,992 02.06.05 US

Filing date 25 May 2006

Wipo publication date 7 December 2006

International Classifications

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/28 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

3 January 2008 PCT application entered the National Phase

  PCT publication WO2006/130458 Priority application(s): WO2006/130458

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006252735-Intervertebral disc and insertion methods therefor

2006252730-Bioresorbable polymer matrices and methods of making and using the same